Literature DB >> 27802452

Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data.

Alex J Walker, David R Baldwin, Tim R Card, Helen A Powell, Richard B Hubbard, Matthew J Grainge.   

Abstract

Entities:  

Year:  2016        PMID： 27802452      PMCID： PMC5355917          DOI： 10.1038/bjc.2016.364

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
Correction to: British Journal of Cancer (2016) 115, 115–121; doi:10.1038/bjc.2016.143; Published online 2 June 2016 The authors of the above paper have recognised that they unintentionally omitted information about their funding sources from their paper. The funding statement is included below. The authors apologise for this oversight. This study was funded by a Population Research Committee project grant from Cancer Research UK (ref: C17683/A12079).
  3 in total

1.  Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients.

Authors:  Federico Nichetti; Francesca Ligorio; Emma Zattarin; Diego Signorelli; Arsela Prelaj; Claudia Proto; Giulia Galli; Antonio Marra; Giulia Apollonio; Luca Porcu; Filippo de Braud; Giuseppe Lo Russo; Roberto Ferrara; Marina Chiara Garassino
Journal:  Cancers (Basel)       Date:  2019-12-25       Impact factor: 6.639

2.  Risk factors and prognosis value of venous thromboembolism in patients with advanced non-small cell lung cancer: a case-control study.

Authors:  Qian Shen; Xiaoqi Dong; Xiaoping Tang; Jianying Zhou
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

3.  Correlation between clinicopathological characteristics of lung adenocarcinoma and the risk of venous thromboembolism.

Authors:  Yuan Zhang; Zhongyue Shi; Jiawen Yi; Jin Zhao; Shu Zhang; Wei Feng; Min Zhu; Bin Hu; Yuhui Zhang
Journal:  Thorac Cancer       Date:  2021-12-04       Impact factor: 3.500
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.